Preconditioning effects of adenosine in patients with severe coronary artery disease but preserved coronary flow reserve

Coronary Artery Disease

Volumn 20, Issue 5, 2009, Pages 354-359

  Sadigh, Bita ^a   Shahgaldi, Kambiz ^a   Sylvén, Christer ^a   Quintana, Miguel ^a   Winter, Reidar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenosine; Contrast echocardiography; Preconditioning; Tissue Doppler echocardiography

Indexed keywords

ADENOSINE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG INFUSION; DRUG MEGADOSE; EXERCISE TEST; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRESS ECHOCARDIOGRAPHY; TISSUE DOPPLER IMAGING;

ADENOSINE; AGED; CARDIOVASCULAR AGENTS; CONTRAST MEDIA; CORONARY ARTERY DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 68049118837     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32832ac5c1     Document Type: Article

References (24)

1. Headrick JP, Hack B, Ashton KJ. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol 2003; 285:H1797-H1818. (Pubitemid 37305920)
2. Reichelt ME, Willems L, Molina JG, Sun CX, Noble JC, Ashton KJ, et al. Genetic deletion of the A1 adenosine receptor limits myocardial ischemic tolerance. Circ Res 2005; 96:363-367. (Pubitemid 40279911)
3. Lukashev D, Ohta A, Sitkovsky M. Targeting hypoxia-A(2A) adenosine receptor-mediated mechanisms of tissue protection. Drug Discov Today 2004; 9:403-409. (Pubitemid 38479685)
4. Peart JN, Gross GJ. Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. Am J Physiol Heart Circ Physiol 2003; 285:H81-H89.
5. Peart JN, Gross GJ. Cross-talk between adenosine and opioid receptors. Drug News Perspect 2005; 18:237-242.
6. Dobson GP, Jones MW. Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg 2004; 127:794-805.
7. Mariani J, Ou R, Bailey M, Rowland M, Nagley P, Rosenfeldt F, Pepe S. Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J Thorac Cardiovasc Surg 2000; 120:660-667. (Pubitemid 30766194)
8. Headrick JP, Willems L, Ashton KJ, Holmgren K, Peart J, Matherne GP. Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression. J Physiol 2003; 549:823-833. (Pubitemid 36889772)
9. Sylven C, Beermann B, Edlund A, Lewander R, Jonzon B, Mogensen L. Provocation of chest pain in patients with coronary insufficiency using the vasodilator adenosine. Eur Heart J 1988; 9 (Suppl):6-10. (Pubitemid 19084619)
10. Sylven C, Beermann B, Jonzon B, Brandt R. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J (Clin Res Ed) 1986; 293:227-230. (Pubitemid 16064218)
11. Sadigh-Lindell B, Sylven C, Hagerman I, Berglund M, Terenius L, Franzen O, Eriksson BE. Oscillation of pain intensity during adenosine infusion. Relationship to beta-endorphin and sympathetic tone. Neuroreport 2001; 12:1571-1575.
12. Segerdahl M, Ekblom A, Sollevi A. The influence of adenosine, ketamine, and morphine on experimentally induced ischemic pain in healthy volunteers. Anesth Analg 1994; 79:787-791. (Pubitemid 24307164)
13. Barbagelata A, Di Carli MF, Califf RM, Garg J, Birnbaum Y, Grinfeld L, et al. Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial. Am Heart J 2005; 150:659-665. (Pubitemid 41396494)
14. Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J 2006; 27:2400-2405.
15. Quintana M, Hjemdahl P, Sollevi A, Kahan T, Edner M, Rehnqvist N, et al. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study. Eur J Clin Pharmacol 2003; 59:1-9. (Pubitemid 36702752)
16. Madler CF, Payne N, Wilkenshoff U, Cohen A, Derumeaux GA, Pierard LA, et al. Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J 2003; 24:1584-1594. (Pubitemid 37020932)
17. Winter R, Gudmundsson P, Willenheimer R. Feasibility of noninvasive transthoracic echocardiography/Doppler measurement of coronary flow reserve in left anterior descending coronary artery in patients with acute coronary syndrome: a new technique tested in clinical practice. J Am Soc Echocardiogr 2003; 16:464-468. (Pubitemid 36570089)
18. Fraser AG, Payne N, Madler CF, Janerot-Sjoberg B, Lind B, Grocott-Mason RM, et al. Feasibility and reproducibility of off-line tissue Doppler measurement of regional myocardial function during dobutamine stress echocardiography. Eur J Echocardiogr 2003; 4:43-53. (Pubitemid 36204389)
19. Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 1998; 32:1251-1259. (Pubitemid 28522380)
20. Cain P, Baglin T, Case C, Spicer D, Short L, Marwick TH. Application of tissue Doppler to interpretation of dobutamine echocardiography and comparison with quantitative coronary angiography. Am J Cardiol 2001; 87:525-531. (Pubitemid 32178444)
21. Mentzer RM Jr, Birjiniuk V, Khuri S, Lowe JE, Rahko PS, Weisel RD, et al. Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg 1999; 229:643-649. (Pubitemid 30187571)
22. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004; 61:448-460.
23. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994; 76:5-13.
24. Sylven C, Eriksson B, Jensen J, Geigant E, Hallin RG. Analgesic effects of adenosine during exercise-provoked myocardial ischaemia. Neuroreport 1996; 7:1521-1525. (Pubitemid 26281136)